Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-02
2000-01-11
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514566, A01N 4350, A01N 3712
Patent
active
06013660&
ABSTRACT:
Methods and associated compositions are provided for the effective treatment of mammalian disease conditions associated with infection by pathogenic organisms through the identification of extracellular enzymes necessary for the growth or survival of the pathogenic organism and the subsequent interference with the functional activity of the identified extracellular enzyme to an extent sufficient to significantly inhibit the growth or survival of the pathogenic organism.
REFERENCES:
patent: 3888837 (1975-06-01), Tsumita et al.
patent: 3943119 (1976-03-01), Tsumita et al.
patent: 4123427 (1978-10-01), Daniel
patent: 4285931 (1981-08-01), Limjuco et al.
patent: 4460503 (1984-07-01), Savrda et al.
patent: 4724144 (1988-02-01), Rook et al.
patent: 4777130 (1988-10-01), Maes
patent: 4889800 (1989-12-01), Shinnick et al.
patent: 4906742 (1990-03-01), Young et al.
patent: 4952395 (1990-08-01), Shinnick et al.
patent: 4965192 (1990-10-01), Maes
patent: 4976958 (1990-12-01), Shinnick et al.
patent: 5108745 (1992-04-01), Horwitz
patent: 5154923 (1992-10-01), Van Eden et al.
patent: 5169940 (1992-12-01), Patarroyo
patent: 5171839 (1992-12-01), Patarroyo
patent: 5225324 (1993-07-01), McFadden et al.
patent: 5254459 (1993-10-01), Patarroyo
patent: 5268170 (1993-12-01), Van Eden et al.
Berendsen, A glimpse of the holy grail, Science, vol. 282, pp. 642-643, Oct. 1998.
McBean, Imhibition of glutamate transporter and glial enzymes in rat striatum by glioxin, [alpha]aminoadipate, Br. J. Pharm., vol. 113, pp. 536-540, 1994.
E. Ribi et al., "Induction of Resistance to Tuberculosis in Mice . . . Unrelated Materials," 1982, 345-356, Zbl.Bakt.Hyg., I.
H. Hahn, "Antibacterial Defence Mechanisms," 1983, S112-S121, Infection II (1983) Suppl.2.
I.M. Orme & F.M. Collins, "Infection with Mycobacterium kansasii and efficacy of vaccination against tuberculosis," 1983, 581-586, Immunology.
P.H. Lagrange et al., "Immunological Mechanisms Controlling Mycobacterial Infections," 1983, 163-172, Bull.europ.Physiopath.resp.
R.A. Young et al., "Dissection of Mycobacterium tuberculosis antigens using recombinant DNA," May 1985, 82:2583-2587, Proc.Natl.Acad.Sci. USA.
B.R. Bloom et al., "Genes for the protein antigens of the tuberculosis and leprosy bacilli," 1985, 5:839-845, Science Reports.
S.H.E. Kaufmann, "T Cell Clones and their Products: . . . Infections," 1985, S177-S182, Infection 13 (1985) Suppl.2.
E. Krambovitis, "Detection of antibodies to Mycobacterium tuberculosis plasma . . . assay," 1986, 21:257-264, Med. Microbiol.
D. Young et al., "Immunological Activity . . . Mycobacterium tuberculosis," Oct. 1986, 177-183, Infection and Immunity, vol. 54, No. 1.
F. Emmrich et al., "A Recombinant 64 Kilodalton Protein . . . Mycobacterial Antigens," Apr. 1986, 163:1024-1029, J.Exp.Med.
A.S. Mustafa et al. "Characteristics of human T-cell clone . . . patients," 1986, 57:123-130, Sympos. on the Immunology of Leprosy, Lepr rev.Suppl. 2.
P.E.M. Fine, "The relationship between delayed type hypersensitivity . . . mycobacterial vaccines in man," 1986, 57:275-283, Lepr.Rev., Suppl. 2.
W.J. Britton et al., "Immunoreactivity of a 70 kD Protein . . . Chromatography," Sep. 1986, 691-708, J .Exp.Medicine.
Ian M. Orme, "The Kinetics of Emergence and Loss . . . Mycobacterium Tuberculosis," Jan. 1, 1987, 138:293-298, The Journal of Immunology.
R.F. Breiman & M.A.Horwitz, "Guinea Pigs Sublethally Infected . . . Challenge," Mar. 1987, 164:799-811, J. Exp. Med.
F.M. LaForce, "Immunizations, Immunoprophylasix . . . Infections," May 8, 1987, 257(18):2464-2470, JAMA.
A. Worsaae et al., "Allergenic and Blastogenic Reactivity . . . Guinea Pigs," Dec. 1987, 55(12):2922-2927, Infection and Immunity.
Roche, Paul W., et al. "T-Cell Determinants and Antibody Binding Sites on the Major Mycobacterial Secretory Protein MPB59 of Mycobacterium bovis." Infection and Immunity 62 (Dec. 1994) 5319-26.
Horwitz, Marcus A., et al. "Protective Immunity Against Tuberculosis Induced by Vaccination with Major Extracellular Proteins of Mycobacterium tuberculosis." Proceedings of the National Academy Science USA 92 (Feb. 1995) 1530-34.
Silver, Richard F., et al., "T-Cell Epitopes of the 39kD Alpha Antigen of Mycobacterium tuberculosis BCG: Potential for Use in Vaccines and Diagnosis." Journal of Cellular Biochemistry--Molecular Mechanisms in Tuberculosis from the Keystone Symposia on Molecular & Cellular Biology, Supplement 19B, 1995 (Feb. 5-Mar. 15, 1995) Abstract No. B3-336: 94.
Huygen, Kris, et al. "Immunogenicity of a Tuberculosis DNA Vaccine Containing Genes Encoding the Components of the Secreted Antigen 85 Complex." Journal of Cellular Biochemistry--Molecular Mechanisms in Tuberculosis from the Keystone Symposia on Lolecular & Cellular Biology, Supplement 19B, 1995 (Feb. 5-Mar. 15, 1995) Abstract No. B3-408.
Orme, Ian M., et al. "T Lymphocytes Mediating Protection and Cellular Cytolysis During the Course of Mycobacterium tuberculosis Infection." The Journal of Immunology 148 Jan. 1992) 189-96.
Young, D.B., et al. "Mycobacterial Protein Antigens: A Compilation." Molecular Microbiology 6, No. 2 (1992) 133-45.
Lee, Byong-Wha Esther, et al. "Cell-Mediated Immune Responses to the Native 71kD Protein of Mycobacterium tuberculosis in Guinea Pigs and Humans." From the Twenty-Seventh U.S.-Japan Leprosy Research Conference, Tuberculosis Research Conference, and Leprosy/Tuberculosis Symposium(Aug 4-7, 1992).
Horwitz, Marcus A., et al. "Progress in the Development of a Subunit Vaccine Against Tuberculosis." From the Twenty-Ninth U.S.-Japan Leprosy Research Conference, Tuberculosis Research Conference, and Leprosy/Tuberculosis Symposium (Aug. 19-22, 1994).
Bloch, Hubert, and William Segal. "Viability and Multiplication of Vaccines in Immunization Against Tuberculosis." American Review of Tuberculosis 7 (1955) 228-48.
Palmer, C., et al., "Experimental Studies of Vaccination, Allergy, and Immunity in Tuberculosis." Bulletin of the World Health Organization 12 (1955) 47-62.
Dubos, Re'ne J., et al. "Antituberculous Immunity Induced in Mice by Vaccination with Living Cultures of Attenuated Tubercle Bacilli." Journal of Experimental Medicine 97 (1953) 207-20.
Youmans, G.P. "Acquired Immunity in Tuberculosis." Chap. 8 in Tuberculosis. Edited by G.P. Youmans. Philadelphia: The W.B. Saunders Co. (1979).
Weiss, David W., and A.Q. Wells. "Immunization with Dead Tubercle Bacilli." Tubercle 37 (Apr. 1956) 137-40.
Meyer, Sven Nissen. "Animal Studies on Effects of BCG, H37Ra and Mycobacterium phlei in Tuberculosis Immunization." Tubercle 37 (Jan.-Feb. 1956) 11-22.
Wilson, G.S., and A.A. Miles, "Tuberculosis." Chap. 59 in Topley and Wilson's Principles of Bacteriology and Immunity. 4th ed. 2 vols. London: Edward Arnold (Publishers) Ltd. (1955).
Kubica, George P., and Lawrence G. Wayne, eds. The Mycobacteria: A Sourcebook. 2 parts. New York: Marcel Dekker, Inc. 33-57.
Infectious Diseases Society of America. Reviews of Infectious Diseases 11. Supplement 2. Chicago: The University of Chicago Press (Mar.-Apr. 1989).
Styblo, Karel. "Overview and Epidemiologic Assessment of the Current Global Tuberculosis Situtation with an Emphasis on Control in Developing Countries." S339-46.
Grosset, Jacques H. "Present Status of Chemotherapy for Tuberculosis." S347-52.
Fine, Paul E.M. "The BCG Story: Lessons from the Past and Implications for the Future." S353-9.
Pio, Antonio. "Impact of Present Control Methods on the Problem of Tuberculosis." S360-5.
Stead, William W. "Pathogenesis of Tuberculosis: Clinical and Epidemiologic Perspective." S366-8.
Dannenberg, Arthur M., Jr. "Immune Mechanisms in the Pathogenesis of Pulmonary Tuberculosis." S369-78.
Quinn, Thomas C. "Interactions of the Human Immunodeficiency Virus and Tuberculosis and the Implications for BCG Vaccination." S379-84.
Smith, Donald W., and Ernst H. Wiegeshaus. "What Animal Models Can TeachUs about the Pathogenesis of Tuberculosis in Humans." S385-93.
De Vries, Re'ne R.P. "Regulation of T Cell Responsiveness Against Mycobacterial Antigens by HLA Class 2 Immune Response Genes." S400-3.
Jacobs, William R., Jr., et al. "Mycobacteriophage Vector
Harth Gunter
Horwitz Marcus A.
Degen Nancy
The Regents of the University of California
Wang Andrew
LandOfFree
Externally targeted prophylactic and chemotherapeutic method and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Externally targeted prophylactic and chemotherapeutic method and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Externally targeted prophylactic and chemotherapeutic method and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462613